The study was carried out at 24 clinical sites across the UK and included 303 participants.

A manufacturing problem in Abbott glucose sensors for diabetes patients has been tied to at least seven deaths and hundreds of injuries worldwide.

Objectives This study aimed to evaluate the effectiveness, safety and costs of FreeStyle Libre (FSL) glucose monitoring system for children and adolescents with type 1 diabetes mellitus (T1DM) in ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

Misinformation about diabetes can lead to delayed diagnoses, ineffective treatment strategies, and increased health risks. By addressing and dispelling these myths, individuals can make informed ...

Dexcom CGM systems provide automatic blood glucose updates every five minutes. FreeStyle Libre sensors can last up to 15 days and no longer need frequent scanning for updates. Both Dexcom and ...

Abbott has launched the FreeStyle Libre 2 Plus in India, a state-of-the-art continuous glucose monitoring system providing real-time readings and alerts for diabetics. This innovative device aims to ...

Gestational diabetes (GD) is diabetes that can occur during pregnancy. Individuals with GD may benefit from wearing a device called a continuous glucose monitor (CGM), which monitors blood sugar ...

Multiple developers of connected diabetes hardware have announced plans this week to link their insulin pumps with continuous glucose monitors from Abbott—including its current FreeStyle Libre system ...

ABBOTT PARK, Ill., April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology 1, today announced that it has entered a ...

MISSISSAUGA, ON, Dec. 17, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2 * flash glucose monitoring system to the Alberta Drug ...